Mahmoud M. Iravani

Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration

Mahmoud M. Iravani, K Kashefi, Palwinder K. Mander et al. · Neuroscience · 2002 · 245 citations

Inflammation, Neurodegenerative Diseases, Reactive Nitrogen Specie +12

The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation

Mahmoud M. Iravani, Clement Leung, Mona Sadeghian et al. · European Journal of Neuroscience · 2005 · 122 citations

In 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Primates, the Selective 5-Hydroxytryptamine 1a Agonist (R)-(+)-8-OHDPAT Inhibits Levodopa-Induced Dyskinesia but Only with\ Increased Motor Disability

Mahmoud M. Iravani, Kayhan A. Tayarani‐Binazir, Wing B. Chu et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 110 citations

3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates

Mahmoud M. Iravani, Michael S. Jackson, Mikko Kuoppamäki et al. · Journal of Neuroscience · 2003 · 105 citations · Full text

Motor Dysfunction, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated Primates, Psychopharmacology +19

Age-associated changes in protein oxidation and proteasome activities in rat brain: Modulation by antioxidants

Manal M. Abd El Mohsen, Mahmoud M. Iravani, Jeremy P.E. Spencer et al. · Biochemical and Biophysical Research Communications · 2005 · 85 citations

Alzheimer's Disease, Aging, Longevity +11